Global Regenerative Artificial Skin Market Overview
Regenerative Artificial Skin Market was valued at US$ 2523.73 Billion in 2024 and is projected to grow at a CAGR of 8.20% to reach US$ 5500.1Billion by 2034.
The Regenerative Artificial Skin Market focuses on incorporating research and various new developments to support artificial skin regeneration to treat various skin injuries and burns.
Rising skin burns and injuries in an individual are one of the key factors leading to the growth of the target market. These kind of skin injuries require more effective and appropriate treatment, so as to help grow a new skin layer. Most of the treatments associated with skin burns require the incorporation of skin substitutes into the patient’s tissues, eventually boosting the growth of the Regenerative Artificial Skin Market.
For More Report Details, Download Free Sample PDF
Global Regenerative Artificial Skin Market Drivers & Restraints
Rising Incidences of Chronic Wounds to fuel the target market growth
Sedentary lifestyles, poor eating habits, and chronic conditions such as obesity and diabetes all contribute to the formation of chronic wounds. The rising number of patients suffering from diabetes and obesity has increased the demand for quick wound healing, in turn propelling the growth of the Regenerative Artificial Skin Market.
For instance, according to the International Diabetes Federation (IDF), it was estimated that around 463 billion people worldwide had been suffering from diabetes as of 2019; and the figure is anticipated to reach 700 billion by the year 2045.
Furthermore, in 2020, according to the Trust for America’s Health organization, it was reported that the adult obesity rate in the USA was around 42.4%, marking the first time ever that the national percentage had surpassed the 40% threshold.
Constant Increase in the Demand for Temporary as well as Permanent Skin Patches and Materials to boost the target market growth
The constant increase in the demand for temporary as well as permanent skin patches and materials is one of the key factors leading to the growth of the target market. The rising number of patients suffering from chronic wounds has been leading to the increasing demand for skin patches and skin grafts, eventually leading to the growth of the Regenerative Artificial Skin Market.
Restrains:
High cost of surgeries and drug delivery is a key factor restraining the growth of the Regenerative Artificial Skin Market. For instance, in July 2020, according to the CBS NEWS, it was reported that the average price for skin grafting in the United States is 51,170 dollars, before insurance.
Global Regenerative Artificial Skin Market Segmentations & Regional Insights
Regenerative Artificial Skin Market is segmented based on Material Type, End-User and Region.
Material Type Insight
On the basis of Material Type, Regenerative Artificial Skin Market is segmented into Temporary Skin Material, Permanent Skin Material, and Composite Skin Material.
End-Users Insights
On the basis of End-Users, Regenerative Artificial Skin Market is segmented into Clinics, Hospitals, and Burn Care Center.
Regional Insights:
On the basis of Region, the Regenerative Artificial Skin Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the target market in the near future, owing to their advancements in technology, growing number of chronic illnesses, increase in geriatric population and improved healthcare facilities as well as research and development programs.
Report Scope:
Attribute |
Details |
Base year for estimation |
2023 |
Forecast period |
2024 – 2034 |
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
Market Segmentation |
By Material Type - Temporary Skin Material, Permanent Skin Material, and Composite Skin Material. By End-Users - Clinics, Hospitals, and Burn Care Center. |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Regenerative Artificial Skin Market report based on Material Type, End-Users and Region:
Regenerative Artificial Skin Market, By Material Type:
- Temporary Skin Material
- Permanent Skin Material
- Composite Skin Material
Regenerative Artificial Skin Market, By End-Users:
- Clinics
- Hospitals
- Burn Care Center
Regenerative Artificial Skin Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Regenerative Artificial Skin Market Competitive Landscape & Key Players
The key players operating the Regenerative Artificial Skin Market includes, Smith & Nephew, Integra Life Sciences Corporation, Johnson & Johnson Services, Inc., Mylan N.V. and Mallinckrodt plc.
Global Regenerative Artificial Skin Market Company Profile
- Smith & Nephew *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Integra Life Sciences Corporation
- Johnson & Johnson Services, Inc.
- MylanN.V.
- Mallinckrodt plc.
“*” marked represents similar segmentation in other categories in the respective section.
Recent Development:
- In January 2023, bioengineers at Columbia University launched a method to grow engineered skin in three-dimensional shapes, which includes an immaculate "glove" of skin that can be slid onto a severely burned hand.
- In January 2023, Singaporean researchers developed a wearable wound health monitoring patch that is powered by AI and named "PETAL". This patch can provide an early warning if there is deterioration of the wound.
- In January 2023, researchers at the Terasaki Biomedical Innovation Institute (TIBI) created the first electronic skin chip (E-skin chip) for cutting-edge health monitoring. The innovative E-skin patch offers simultaneous and continuous monitoring of several bodily factors, including appropriate temperature, humidity, and breathability.
- In February 2018, AVITA Medical announced that the US Food and Drug Administration approved a "ReCell Autologous Cell Harvesting Device" under the programme, “Compassionate Use Investigational Device Exemption (IDE)”. ReCell is a device that allows doctors to treat injuries and skin lesions using minute samples of the patient's own cells. The operation is carried out at the patient's bedside, takes around 25 minutes, and doesn't need any specialized people, external tissue culture, or laboratory equipment.
Global Regenerative Artificial Skin Market Highlights
FAQs
The Regenerative Artificial Skin Market is segmented into Material Type, End-Users and Region.
Regenerative Artificial Skin Market is driven by factors like rising incidences of chronic wounds and constant increase in the demand for temporary as well as permanent skin patches and materials.
By region, the Regenerative Artificial Skin Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Regenerative Artificial Skin Market includes, Smith & Nephew, Integra Life Sciences Corporation, Johnson & Johnson Services, Inc., MylanN.V. and Mallinckrodt plc.
Regenerative Artificial Skin Market accounted for US$ 2.1 billion in 2022 and is estimated to be US$ 5.6 billion by 2032 and is anticipated to register a CAGR of 10.2%.